Companies like Gilead have made a fortune on anti-viral cures. Case in point: their recent Hepatitis C vaccines, which pulled in $4B in one quarter last year [1]. So a lack of money to be made on cures is not why this isn't funded.

[1] https://www.statnews.com/2016/04/28/gilead-hepatitis-c-reven...